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Natural killer (NK) cells are large granular lymphocytes that express a diverse array of
germline encoded inhibitory and activating receptors for MHC Class I and Class I-like
molecules, classical co-stimulatory ligands, and cytokines. The ability of NK cells to be
very rapidly activated by inﬂammatory cytokines, to secrete effector cytokines, and to kill
infected or stressed host cells, suggests that theymay be among the very early responders
during infection. Recent studies have also identiﬁed a small number of pathogen-derived
ligands that can bind to NK cell surface receptors and directly induce their activation. Here
we review recent studies that have begun to elucidate the various pathways by which
viral, bacterial, and parasite pathogens activate NK cells. We also consider two emerging
themes of NK cell–pathogen interactions, namely their contribution to adaptive immune
responses and their potential to take on regulatory and immunomodulatory functions.
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INTRODUCTION
The innate immune system, comprising large populations of cells
expressing germ line-encoded receptors for non-self molecules,
is designed to provide rapid but generic responses to foreign
organisms. Innate immune cells initiate, amplify, and direct the
subsequent adaptive response via diverse contact-dependent and
cytokine-mediated signals; vaccine adjuvants take direct advan-
tage of this capability (Pashine et al., 2005). Among these innate
cell populations, natural killer (NK) cells – ﬁrst recognized and
named for their ability to kill malignant or transformed cells
(Kiessling et al., 1975) – are now known to play an important role
in the control of intracellular pathogens including viruses, bacte-
ria, and protozoa (Korbel et al., 2004; Lodoen and Lanier, 2006)
and twodistinct pathways of NK cell activation are now recognized
(Figure 1). In the direct “missing-self”pathway,NK cell activation
results from their interaction with somatic cells that lack MHC
Class I ligands for NK inhibitory receptors (Karre et al., 1986;
Karre, 2008). In the absence of inhibitory signals, signals from
activating receptors (recognizing endogenous stress molecules or
pathogen-encoded ligands) lead to induction of NK cell cytotoxic
function and cytokine release. The indirect pathway of NK cell
activation – mediated by myeloid accessory cells responding to
pathogens via diverse pattern recognition receptors by cytokine
release and upregulation of co-stimulatory receptors (reviewed
in Newman and Riley, 2007) and augmented by antigen-speciﬁc
T cells (Horowitz et al., 2010a; Evans et al., 2011) over-rides the
inhibitory signals provided by MHC Class I competent cells. The
various combinations of NK cell receptors that induce different
modes of NK cell effector function have been reviewed (Bryceson
et al., 2006; Lanier, 2008) and are summarized in Figure 2.
The purpose of this article is to review recent developments
in our understanding of how different pathogens induce NK cell
activation; as such this article represents an updating of our previ-
ous article on this subject (Newman and Riley, 2007). We review
recently published studies which extend our understanding of NK
cell activation by viruses, bacteria, and protozoa as well as recent
data revealing that NK cells may also inﬂuence the outcome of
fungal and helminth infections.
NK CELLS AND VIRUSES
The role of NK cells in controlling viral infections has been long
recognized (Biron and Brossay, 2001). Many viruses modify the
surface membrane of their host cell, leading to down regulation of
MHCclass Imolecules and/or upregulation of host-derived stress-
related molecules which mark the infected cell as “abnormal” and
lead to NK cell-mediated killing. The role of accessory cell-derived
co-stimulatory signals in NK cell activation during viral infection
has also been long recognized (Biron et al., 1999), indicating that
both the direct and indirect pathways of NK cell activation are
likely to contribute to their control of viral infections.
DIRECT ACTIVATION OF NK CELLS DURING VIRAL INFECTION
Evidence for direct NK cell activation during viral infection came
from the discovery that inﬂuenza hemagglutinin binds to NKp46
on human NK cells and induces cytotoxic activity (Mandelboim
et al., 2001). At more or less the same time, it was found that the
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FIGURE 1 | Direct and indirect activation of NK cells.The “classical”
pathway of NK cell activation (A,B) results from skewing of the balance
between signals transmitted via inhibitory and activating receptors. Inhibitory
receptors, such as the Ly49 lectin-like receptors in mice (A) and the killer cell
immunoglobulin-like receptors (KIR) in humans (B) bind MHC class I
molecules. These MHC class I molecules may contain either self or foreign
(antigenic) peptides within the peptide binding groove and there is increasing
evidence that the nature of the bound peptide may inﬂuence the afﬁnity of
receptor–MHC interactions. In the absence of appropriate inhibitory
interactions (due to down regulation of MHC or expression of foreign MHC
molecules which provide no ligands for polymorphic inhibitory receptors),
activating signals may predominate, leading to production of effector
molecules, and direct killing of target cells. Activating ligands include
stress-induced ligands on infected or transformed cells and virus-encoded
ligands. For example, during infection with murine cytomegalovirus (MCMV),
the activating receptor Ly49H recognizes the MCMV-derived MHC class I-like
molecule, m157, which leads to direct killing of MCMV-infected target cells
[(A); lower panel]. The “indirect” pathway of NK cell activation results from
contact-dependent and soluble signals derived from accessory cells andT
cells transmitted to activating receptors on NK cells (C). Myeloid accessory
cells recognize pathogens via PRRs, secrete cytokines, and upregulate
co-stimulatory molecules. Accessory cells also present antigen to CD4+T
cells and provideT cell co-stimulation; activatedT cells secrete IL-2 which
synergizes with accessory cell signals to potentiate the activation of NK cells.
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FIGURE 2 | Nature killer cell activating signals from myeloid accessory
cells andT cells. Following recognition of pathogen by PRRs, accessory cells
(in blue, above) become activated and transmit signals (both
contact-dependent and -independent) to activating receptors on NK cells (in
purple, below). This ﬁgure summarizes those for which there is the strongest
experimental evidence, but is not exhaustive.
m157 glycoprotein of murine cytomegalovirus (MCMV) binds to
the NK cell activating receptor Ly49H and that strains of mice,
which express Ly49H are highly resistant to MCMV infection.
Ly49H binding of m157 is entirely sufﬁcient for NK cell activation
and MCMV elimination (Daniels et al., 2001; Arase et al., 2002;
Smith et al., 2002). Mouse NK cells can also be induced to secrete
IFN-γ by interaction of the activating receptor Ly49P with H2-Dk
of MCMV-infected cells; recognition of MCMV-infected cells is
dependent on the viral proteinm04,butm04 alone is not sufﬁcient
for activation of Ly49P+ NK cells (Kielczewska et al., 2009).
Viral envelope proteins of two ﬂaviviruses (West Nile virus and
Dengue virus) bind to NKp44 (Hershkovitz et al., 2009) how-
ever, as NKp44 is only expressed on IL-2-activated NK cells (Vitale
et al., 1998), it is likely that the NK cells also require signals from
accessory cells in order to respond to these two viruses.
NK cells mediate antiviral activity in the very early phase
of infection with poxviruses such as vaccinia virus (VV) and
ectromelia virus (ECTV; Parker et al., 2007). During ECTV infec-
tion, the activating receptor NKG2D induces NK cytotoxicity
and controls virus dissemination (Fang et al., 2008) but during
VV infection cytotoxicity is regulated by NKp30, NKp44, and
NKp46 (Chisholm and Reyburn, 2006). Poxvirus hemagglutinins
are ligands for NKp30 and NKp46; hemagglutinin blocks NKp30-
dependent activation but induces NKp46-dependent activation
(Jarahian et al., 2011). NK cells also recognize ECTV infected cells
by binding of the CD94–NKG2E heterodimer to the MHC class Ib
molecule Qa-1b (Fang et al., 2011); CD94 expression is essential
for resistance to ECTV as NK cells from CD94-deﬁcient mice are
unable to prevent virus dissemination (Fang et al., 2011).
There is accumulating evidence that direct interactions between
MHC Class I/Class 1-like molecules on target cells and MHC
receptors onNKcells inﬂuence the outcome of chronic virus infec-
tions. Inhumans, thepolymorphic killer cell immunoglobulin-like
receptors (KIRs) bind to HLA Class 1 molecules and trans-
duce (mainly) inhibitory signals. The strength of the interaction
between particular KIRs and their particular HLA/peptide ligands
determines the threshold for NK cell activation and thus, poten-
tially, viral clearance (Alter et al., 2011a; Fadda et al., 2011). Thus,
expression of the inhibitory NK cell receptor KIR2DL3 in combi-
nation with its ligand HLA-C1 has been associated with clearance
of acute hepatitis C virus (HCV) infection (Khakoo et al., 2004)
and with positive outcomes of treatment of chronic HCV infec-
tion with pegylated IFNα and ribavirin. Individuals expressing an
alternate receptor,KIR2DL2, tend to respond less well to treatment
(Yoon et al., 2009), which may reﬂect the stronger binding afﬁnity
of KIR2DL2 to HLA-C1, leading to greater inhibition of NK cells.
Recent studies have demonstrated that the nature of the pep-
tide bound within the HLA Class I groove can inﬂuence KIR–HLA
interactions. HLA-C1 binding peptides can modify binding to
KIR2DL2 and KIR2DL3 with signiﬁcant knock-on effects on NK
cell activation (Fadda et al., 2011). Moreover, non-synonymous
polymorphisms in the HIV-1 sequence are reported to select for
increased recognition and binding by KIR2DL2 in chronically
HIV-infected donors (Alter et al., 2011a). Finally, the recent sug-
gestion that the terminalD0domain of KIR3DL2bindsCpGDNA,
leading to KIR internalization and shuttling of the CpG to early
endosomes where it binds to TLR9 and activates the NK cell offers
an intriguing new route by which a variety of microparasites,
including viruses, might directly activate NK cells (Sivori et al.,
2011).
The roles of other NK cell surface receptors during viral infec-
tions remain somewhat unclear. Reports that NK cell effector
functions can be inhibited by cross linking of CD81 (a receptor for
HCV viral entry into cells) on NK cells by HCV envelope protein
2 (Crotta et al., 2002, 2010; Tseng and Klimpel, 2002) have been
challenged by a recent report showing that HCV envelope protein
2, as part of intact and infectious HCV virions, does not alter NK
cell function (Yoon et al., 2009). Several studies have investigated
NK receptor expression in chronic HCV virus infection – with
rather mixed results (reviewed in Cheent and Khakoo, 2011).
Recently it was reported that expression of the activating receptor
NKG2D is upregulated on peripheral blood NK cells of individu-
als with acute HCV infection (Amadei et al., 2010) although this
did not correlate with the outcome of infection (i.e., chronic or
self-limited infection), NK cells of patients with acute HCV pro-
duced more IFN-γ upon IL-12 stimulation than those of healthy
www.frontiersin.org January 2012 | Volume 2 | Article 88 | 3
Horowitz et al. Cells and infection
controls suggesting that they aremaintained in a partially activated
state (Amadei et al., 2010). On the other hand, the percentages of
NKG2D+ (as well as NKp30+ and NKp46+) peripheral blood NK
cells are reportedly decreased in patients with acute, chronic, and
resolved HCV infections whilst NKG2A+ and CD94+ NK cells
were found to be raised in acute and chronic HCV infection but
not in resolved infection (Alter et al., 2011b). Moreover, despite
increased expression of the NKG2D ligands MICA and MICB on
hepatocytes, chronic HCV infection is reportedly associated with
down modulation of NKG2D on circulating NK cells leading to
decreased NK cell-mediated cytotoxic killing and IFN-γ produc-
tion (Sene et al., 2010). Further studies are required to determine
whether the phenotype of these peripheral NK cells reﬂects the
phenotype of NK cells trafﬁcking into the infected liver.
INDIRECT ACTIVATION OF NK CELLS DURING VIRAL INFECTION
The indirect pathway of NK cell activation is well-described for
many viruses, including herpes viruses such as MCMV and herpes
simplex virus-1 (HSV-1), and involves secretion of type I inter-
ferons (IFNs) and IL-12 from plasmacytoid dendritic cells (pDCs;
Dzionek et al., 2001; Dalod et al., 2003; Krug et al., 2004a; Zucchini
et al., 2008; Steinberg et al., 2009;Amadei et al., 2010).NK cell IFN-
γ production appears to be particularly dependent upon sustained
IL-12 production whereas NK cell cytotoxicity can be maintained
in the presence of either IFN-α or IFN-β (Steinberg et al., 2009).
In the early phase of MCMV infection, IFN-α and IL-12 pro-
duction is dependent on MyD88/TLR9 signaling (Delale et al.,
2005; Zucchini et al., 2008). In the later phases of infection, IFN-α
production (and hence NK cell cytotoxicity) is maintained in an
increasingly pDC- and MyD88-independent manner whereas NK
cell IFN-γ production is impaired in the latter phase of infec-
tion due to reduced availability of IL-12 (Delale et al., 2005).
The availability of mice expressing the diphtheria toxin recep-
tor under control of the pDC-speciﬁc promoter BDCA-2 – in
which pDCs are selectively depleted by administration of diph-
theria toxin – has revealed that pDC depletion during the early
stages of MCMV infection leads to reduced IFN-α/β production
and enhanced MCMV burden (Dzionek et al., 2001; Swiecki et al.,
2010). Accordingly, pDCs seem to be involved in activation of NK
cells in the early phase of infection, but expansion of Ly49H+ NK
cells in the later phase of infection is independent of pDCs. For
HSV-1, IFN-α, and IL-12 production from pDCs is dependent on
MyD88/TLR9 signaling but mice lacking either MyD88 or TLR9
are able to control HSV-1 infection (Krug et al., 2004a), suggest-
ing that alternate pathways are available for NK cell activation.
Depletion of pDCs during infection with the rhabdovirus vesic-
ular stomatitis virus (VSV) also allows for signiﬁcantly enhanced
viral replication in the very early phase of infection, suggesting an
important role for pDCs in clearance of diverse viral infections
(Swiecki et al., 2010). Nevertheless, CD11b+ myeloid (m) DCs
can also mediate IFN-α/β-dependent NK cell activation during
MCMV infection (Andoniou et al., 2005); this appears to be TLR-
9 independent (Andoniou et al., 2005) but requires TLR-2 and/or
TLR-3 signaling (Tabeta et al., 2004; Szomolanyi-Tsuda et al., 2006;
Barbalat et al., 2009).
The importance of indirect NK cell activation by cytokines
in controlling virus infections is evident from the evolution of
immune evasion strategies to subvert this pathway. For example,
poxviruses can produce IL-18 binding proteins which inactivate
host IL-18; viral mutants lacking IL-18 binding proteins induce
higher levels of NK cell IFN-γ and cytotoxicity (Born et al., 2000;
Reading and Smith, 2003).
During chronic HCV infection, NK cells express higher than
normal levels of activationmarkers such as CD122 (the IL-2 recep-
tor sub-unit responsible for IL-2 and IL-15 signaling), CD69 and
NKp44 (Oliviero et al., 2009; Ahlenstiel et al., 2010), and IFN-α
induces expression of the TNF-related apoptosis-inducing ligand
(TRAIL; CD253) on liver NK cells (Ochi et al., 2004). TRAIL+
NK cells can kill autologous HCV-infected hepatocytes, a func-
tion which is enhanced by poly(I:C) treatment, although this may
contribute to liver pathology in chronically infected individuals
(Ochi et al., 2004). TRAIL+ NK cells have also been observed in
the livers of patients with chronic hepatitis B virus (HBV) infec-
tion; TRAIL expression onNKcells was temporally associatedwith
liver inﬂammation and hepatocyte expression of a TRAIL death-
inducing receptor (Dunn et al., 2007) but an understanding of
the pathways leading to TRAIL upregulation on NK cells remains
incomplete.
Taken together, these studies support the concept that pDCs
and mDCs can mount a coordinated response to viral infection
by production of type I IFNs, IL-12, and chemokines leading to
recruitment and activation of NK cells (Takeda et al., 2003; Krug
et al., 2004b). However, there are also reports suggesting that,
during MCMV infection, cross-talk between pDCs and mDCs
can inhibit IL-12 production, leading to suppression of IFN-γ-
producing NK cells (Dalod et al., 2003; Amadei et al., 2010) and a
recent study demonstrated that antagonizing IFN-β1, IL-12, and
IFN-γ can prevent HCMV-induced down regulation of NKG2D
on NK cells and thus reverse suppression of NKG2D-mediated
cytotoxicity (Muntasell et al., 2010). Inhibition of NK cell function
during chronic HCV infection appears to be mediated by binding
of the HCV non-structural protein 5A to TLR4 on monocytes,
inducing a switch from IL-12 to IL-10 secretion and induction of
TGF-β; NKG2D expression and NK cell function could be restored
with exogenous IL-15 (Sene et al., 2010). This is in linewith reports
of a positive feedback loop of type-1 IFN and IL-15 production
leading to NK cell cytotoxicity and production of IFN-γ, which
becomes impaired during chronic HCV infection (Jinushi et al.,
2003). In chronic HBV infection, liver NK cell IFN-γ production
and non-cytolytic antiviral functions are also inhibited by IL-10
and/or TGF-β (Peppa et al., 2010), possibly emanating from Kupf-
fer cells (Tu et al., 2008), suggesting that selective modulation of
NK cell function in the liver both prevents viral clearance (perhaps
as a means to prevent immune-mediated liver damage). Suppres-
sion of NK cell IFN-γ secretion is correlated with high HBV viral
load; interventions to reduce viral load appear to restore NK cell
function and may facilitate clearance of the infection (Tjwa et al.,
2011). Taken together, these studies reﬂect an emerging picture
of the ability of the innate immune response to self-regulate dur-
ing chronic infection with cells of myeloid origin guiding both
activation and inhibition of NK cell function.
One of the most interesting recent developments in NK cell
biology – the concept that NK cells may acquire some form of
immunological memory – has emerged directly from studies of
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viral infections. Although ﬁrst observed during studies of delayed
hypersensitivity (O’Leary et al., 2006), enhanced NK cell func-
tion during secondary, compared to primary, antigen exposure
has now been described for several viral infections; secondary NK
cell responses are virus-speciﬁc, and are independent of adaptive T
and B lymphocytes, but are restricted to a CXCR6+ and/or Thy1+
population of hepatic NK cells (Paust et al., 2010; Gillard et al.,
2011). The molecular basis for these adaptive NK cell response is
currently entirely unclear and there is, as yet, no evidence for simi-
lar responses in humans.However, induction of NK cell“memory”
has been characterized in more detail during MCMV infection.
NK cells expressing the Ly49H receptor, which binds the MCMV
m157 protein, expand during primary MCMV infection and per-
sist at high frequency in both lymphoid and non-lymphoid tissues;
upon reinfection these “primed” or “memory” NK cells prolif-
erate, degranulate, and secrete IFN-γ to a much greater extent
than “naïve” NK cells and confer protective immunity to MCMV
(Sun et al., 2009). The mechanism by which NK cells acquire
this type of memory phenotype is an area of ongoing research
but the fact that a similar phenotype is observed among NK cells
primedbyTLR-activatedDCs and IL-15 (Lucas et al., 2007) or acti-
vated with a cocktail of cytokines (IL-12, IL-18, and IL-15; Cooper
et al., 2009), that NK cell activation during acute HCV infection
(Pelletier et al., 2010) and in response to inﬂuenza A virus (He
et al., 2004) is highly correlated with T cell activation, and that
the frequency of IFN-γ-producing NK cells among re-stimulated
PBMCs is enhanced after inﬂuenza vaccination (Long et al., 2008),
all tend to suggest that NK cells increase in frequency and/or
undergo functional maturation after exposure to viral infection
and/or the concomitant cytokine-mediated inﬂammation. Stud-
ies with protozoal pathogens (Bihl et al., 2010; Horowitz et al.,
2010b; McCall et al., 2010; discussed in more detail below) have
revealed that this“priming”of NK cells is not limited to viral infec-
tions and led to the hypothesis that IL-2 from antigen-speciﬁc T
cells allows NK cells to contribute to the effector arm of adaptive
immune responses (Figure 3). In support of this notion, we have
shown that NK cell responses (CD69 expression, IFN-γ produc-
tion, expression of the degranulation marker LAMP-1 (CD107a),
and release of perforin granules) to inactivated rabies virus (RV)
are augmented in an antigen-speciﬁc, T cell, and IL-2 dependent
manner by vaccination (Horowitz et al., 2010b). Importantly, we
observed that NK cells respond much more quickly than do CD8+
T cells after re-exposure to the vaccine antigen and that NK cells
represent more than 70% of IFN-γ-secreting and cytotoxic cells
during the ﬁrst 24 h after re-exposure to RV. The logical con-
clusion of all of these observations is that antigen-speciﬁc IL-2
secretion from T cells may recruit NK cells as effectors of adaptive
immunity and, thus, that NK cell responses can be potentiated
by vaccination. Whether speciﬁc subsets of human NK cells can
be preferentially reactivated by viruses expressing ligands for par-
ticular NK cell receptors (as suggested by the responsiveness of
Ly49H+ murine NK cells to MCMV m157; Sun et al., 2009)
remains to be seen but, if they can, then the potential for IL-
2 from antigen-speciﬁc T cells to synergize with enhanced direct
activation of “memory”NK cells by pathogen-derived ligands may
lead to even more potent NK cell responses during secondary
infections.
NK CELLS AND BACTERIAL INFECTIONS
Bacteria provide numerous potent ligands for TLRs and other pat-
tern recognition receptors and induce very characteristic inﬂam-
matory responses. Thus, there is considerable potential for indirect
activation of NK cells during bacterial infection and for NK cell-
derived IFN-γ to enhance phagocytosis of extracellular bacteria or
infected host cells by macrophages. Whether bacteria also possess
ligands for NK cell surface receptors, and can thus mediate direct
NK cell activation, is however less well characterized.
DIRECT ACTIVATION OF NK CELLS BY BACTERIA?
Direct binding of Mycobacterium bovis BCG (BCG), Nocardia
farcinica, and Pseudomonas aeruginosa cell wall-derived proteins
to NKp44 – and consequent NK cell activation – has recently
been reported (Esin et al., 2008) however blocking anti-NKp44
antibodies did not inhibit the activation of NK cells. Thus, as pre-
viously discussed for West Nile and Dengue viruses, it is quite
likely that accessory cell- and cytokine-mediated upregulation of
NKp44 is a consequence rather than a cause of NK cell activa-
tion, perhaps serving to potentiate rather than initiate the NK cell
response. Marcenaro et al. (2008) provide evidence that highly
puriﬁed human NK cells directly recognize M. bovis BCG, lead-
ing to their activation and expression of CD69 and CD25, release
of IFN-γ and TNF, and killing of target cells; NK responses were
inhibited by blocking antibodies speciﬁc to TLR-2, and the authors
suggest that NK cells may bear a functional TLR-2 receptor. How-
ever, the bacterial ligands and NK receptors involved have not
been identiﬁed and these ﬁndings are somewhat at odds with
the ﬁndings of other studies (cited below) which demonstrate
essential roles for accessory cell-derived stimuli in NK activation
by BCG.
INDIRECT ACTIVATION OF NK CELLS BY BACTERIA
Indirect activation of NK cells by bacteria is well-described in
numerous systems including Listeria monocytogenes, Staphylococ-
cus aureus,Lactobacillus johnsonii,Mycobacterium tuberculosis, and
M. bovis BCG infections and requires TLR-mediated activation of
mDCs and monocytes to secrete IL-12, IL-18, and type-1 interfer-
ons (Newman and Riley, 2007). NK cell activation by L. monocy-
togenes (following binding of listeriolysin O to TLR-2; Nishibori
et al., 1996; Ito et al., 2005; Datta et al., 2006) is mediated through
production of IL-1β, IL-12, IL-18, and TNF-α from macrophages
and mDCs (Wherry et al., 1991; Tripp et al., 1993; Hunter et al.,
1995; Nomura et al., 2002; Humann and Lenz, 2010) but was
thought to be independent of direct contact with APCs (Wherry
et al., 1991). More recent data indicate that contact between NK
cells and DCs is required (Humann and Lenz, 2010), although the
contact-dependent signals have not been characterized. IL-18 is
required for optimal type-1 inﬂammatory responses, constraint
of bacterial growth, and prevention of neutrophil-mediated lung
damage in M. tuberculosis infected mice (Schneider et al., 2010).
Given reports of the effect of NK cell depletion on dissemination
of murine M. tuberculosis infections (Feng et al., 2006) and of the
ability of bovineNKcells to constrain replicationof M.bovis inside
macrophages (Denis et al., 2007), it is likely that NK cell-mediated
control of Mycobacterium spp. infections may also be impaired in
the absence of IL-18. Certainly, we recently observed that optimal
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FIGURE 3 | Antigen-specific effector memory CD4+ T cells recruit NK cells
as effector cells in adaptive immune responses. During primary infection,
NK cells receive innate activation signals from myeloid accessory cells and
make very limited responses (left). Upon re-exposure to a pathogen,
antigen-speciﬁc CD4+ T cells are a potent and immediate source of IL-2.
Accessory cell signals synergize with this IL-2, resulting in rapid and robust
“adaptive” NK cell responses, including NK cell proliferation, secretion of
effector molecules, and killing of affected target cells (right).
activation of human NK cells by M. bovis BCG requires IL-12 and
IL-18, as well as IL-2 from CD4+ T cells (Evans et al., 2011), sup-
porting and extending previously published ﬁndings (Korbel et al.,
2008; Zhou et al., 2009). On the other hand,NK cells which inhibit
growth of M. tuberculosis via secretion of IL-22 appear to require
exogenous IL-15 and IL-23 but not IL-12 or IL-18 (Dhiman et al.,
2009). It is not yet clear how any of these ﬁndings can be recon-
ciled with those of Marcenaro et al., 2008; above) but differences
in NK responses to virulent and avirulent strains of mycobacteria
may provide some clues.
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Lastly, building on studies initially performed with protozoal
infections (Maroof et al., 2008), studies of acute systemic infec-
tions with L. monocytogenes and Yersinia pestis have found that
NK cells can be a signiﬁcant source of the regulatory cytokine,
IL-10. IL-10 secretion from NK cells suppresses IL-12 secretion by
DCs and thus blocks further NK cell activation (Perona-Wright
et al., 2009); localized infections with an attenuated strain of Y.
pestis or with inﬂuenza virus do not induce this IL-10 response
suggesting that NK cell-derived IL-10 may be required to pre-
vent immune pathology during systemic infections (Figure 4).
The precise signals that lead to IL-10 secretion by NK cells remain
to be determined although, by analogy with studies with HCMV
(Romo et al., 2011), it would seem likely thatmodulation of signals
provided by accessory cells may play a role.
NK CELLS AND PROTOZOAL INFECTIONS
Like bacteria, protozoan parasites induce strong inﬂammatory
responses and activate NK cells via the indirect pathway; rapid NK
cell-derived IFN-γ production is necessary for effective clearance
of many protozoan infections (reviewed in Korbel et al., 2004).
There is, as yet, no strong evidence that protozoa can directly
activate NK cells.
FIGURE 4 | Environmental cues modulate pro-inflammatory and
regulatory NK cell responses. Dendritic cells (DCs) infected with intracellular
bacteria produce IL-12. (A) During localized infections, NK cells respond to
IL-12 by producing IFN-γ, which ampliﬁes the DC IL-12 response, creating an
unregulated feedback loop. The pathogen is killed or contained but at the
expense of signiﬁcant tissue damage. (B) During systemic infection, as yet
uncharacterized differences in the environmental cues provided by accessory
cells (but possibly inﬂuenced by the concentration of IL-12) lead to NK cell
production of IL-10. NK cell-derived IL-10 limits tissue damage but may also
allow the infection to persist.
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Inmice infectedwithPlasmodium chabaudi AS (malaria), IL-12
(Stevenson et al., 1995; Mohan et al., 1997; but not IL-15; Ing and
Stevenson, 2009) enhances NK cell cytotoxicity, IFN-γ and TNF-
α production, facilitates clearance of infection, and primes DCs
for efﬁcient presentation of antigen to CD4+ T cells. Rapid and
potent human NK cell IFN-γ responses are induced in vitro by P.
falciparum-infected redblood cells (iRBC) in an accessory cell-, IL-
12-, and IL-18-dependent manner (Artavanis-Tsakonas and Riley,
2002; Artavanis-Tsakonas et al., 2003; Baratin et al., 2005). Having
observed that NK cell activation by P. falciparum iRBC is depen-
dent on IL-2 and that – although myeloid cells were essential for
NK cell activation – the NK cell response within mixed peripheral
blood mononuclear cells could not be recapitulated by addition
of myeloid cells (plastic adherent monocytes, macrophages, and
DCs) to puriﬁedNK cells (Newman et al., 2006),we found thatNK
cell activation is highly dependent on IL-2 from antigen-speciﬁc
CD4+ T cells (Horowitz et al., 2010a). Thus, as described above
for RV and BCG, IL-2 from memory CD4+ T cells synergizes with
myeloid accessory cell-derived stimuli leading to optimal NK cell
responses to P. falciparum iRBC. In line with these observations,
NK cell responses to P. falciparum iRBC are potentiated (in a T
cell dependent manner) in individuals recovering from primary
malaria infections (McCall et al., 2010) and NK cell responses to a
malaria sporozoite antigen are enhanced by vaccination (Horowitz
et al., submitted for publication).
Natural killer cell dependency on T cell-derived signals has also
been recently reported for Leishmania major infection in mice.
It has long been known that DC-derived IL-12 and IL-18 are
required for induction of NK cell IFN-γ production and cytotox-
icity by L. major (Scharton-Kersten et al., 1995; Wei et al., 1999);
this response is mediated by TLR-9 (Liese et al., 2007). It is now
clear that NK cell responses to L. major also require both IL-2
and CD40–CD40L co-stimulation from primed, antigen-speciﬁc
CD4+ T cells (Bihl et al., 2010). Indeed, the DC and T cell path-
ways of NK cell activation by L. major may both depend on TLR-9
since treatment of L. major-infected mice with the TLR-9 ago-
nist CpG leads to very rapid secretion of IL-2 as well as robust
production of IFN-γ by NK cells (Laabs et al., 2009). Similarly,
both mDCs and pDCs secrete IL-12 in a TLR-9-dependent man-
ner during L. infantum infection; although pDCs also produce
IFN-α/β, only the mDCs are able to internalize the parasite. It is
not yet known whether murine NK cells can bind and internal-
ize CpG for binding to TLR-9 (as recently reported for human
NK cells; Sivori et al., 2011). Depletion of pDCs has no effect
on NK cell IFN-γ production or cytotoxicity but depletion of
mDCs abolishes the NK cell response, providing direct in vivo
evidence of NK cell dependency on signals from mDCs (Schle-
icher et al., 2007). A recent study of murine L. donovani infection
has revealed for the ﬁrst time that the anti-leishmanial role of
splenic NK cells is dependent upon physical contact between NK
cells and the infected macrophage (Manna et al., 2010). How-
ever, although NK cells made sustained contact with infected
macrophages their anti-leishmanial role was non-cytolytic and
conﬁned to TNF-α production (Manna et al., 2010), suggesting
that the contact-dependent signals are required to fully activate
the NK cell rather than for the NK cell to deliver a death signal to
the macrophage.
Natural killer cells can themselves be infected byT. gondii (Pers-
son et al., 2009):NKcells lyse infectedDCs in aperforin-dependent
manner leading to egress of viable T. gondii that rapidly infect the
surrounding NK cells offering a potential route for immune eva-
sion. In T. gondii-infected mice, MyD88 signaling is required for
IL-12 secretion by DCs and consequent NK cell activation (Hou
et al., 2011). Toxoplasma proﬁlin is a known ligand for TLR-11 (a
receptor that is non-functional in humans) and a potent activa-
tor of murine DCs (Yarovinsky et al., 2005). Surprisingly, in the
absence of TLR-11 NK cells of T. gondii-infected mice secrete very
high levels of IFN-γ and there is extensive destruction of pan-
creatic tissue and fat necrosis (Yarovinsky et al., 2008) suggesting
that TLR-11 signaling is required to regulate the NK cell response
and prevent immunopathology. This is reminiscent of the role of
DCs in regulating NK cell responses to viruses, as described above.
The recent demonstration that NK cells are a major source of IL-
17 during early T. gondii infection, that this response is largely
dependent on APC-derived IL-6, IL-23, and TGF-β and that it is
inhibited by exogenous IL-2, IL-15, and IL-27 (Passos et al., 2010)
raises the possibility that TLR-11 signaling in DCs is required to
prevent excessive NK IL-17-mediated immune pathology, but this
hypothesis is, as yet, untested.
NK CELL RESPONSES TO HELMINTHS
Effective control of helminth infections typically depends on a
highly polarized type-2 immune response, characterized by secre-
tion of IL-4, IL-5, and IL-13, secretion of IgE antibodies and activa-
tion of mast cells (Allen and Maizels, 2011). Relatively few studies
have examined the potential for NK cells to either contribute to, or
to modulate, immune responses to helminths but this possibility
has recently begun to attract the attention of helminth immunol-
ogists. Excretory/secretory (ES) products of the nematode Necator
americanus (but not comparable products of other nematodes)
have been reported to bind selectively to CD56bright NK cells and,
in the presence of sub-optimal concentrations of IL-2 and IL-12,
to induce NK cell IFNγ production (Hsieh et al., 2004) suggesting
that protein or glycoprotein components of the N. americanus ES
may be able to bind to activating NK cell receptors and lower the
NK cell threshold for activation. NK cells from N. americanus-
infected individuals spontaneously produce IFN-γ ex vivo but fail
to bind exogenous biotin-labeled ES, suggesting that their circu-
lating NK cells may have already bound (and been activated by)
endogenous ES ligands (Teixeira-Carvalho et al., 2008).
In murine gastro-intestinal nematode infections there is accu-
mulating evidence that, when there is a disruption of Th2 immu-
nity, NK cells (particularly those of male mice) may become an
important source of the protective type-2 cytokine, IL-13 (McDer-
mott et al., 2005; Hepworth and Grencis, 2009). Depletion of Th2
CD4+Tcells, themain source of IL-13, results in complete abroga-
tionof wormexpulsion,but depletionof NKcells results in delayed
expulsion only in male mice. There is no information, as yet,
regarding the signals that induceNK cells to secrete IL-13 although
it may be relevant that the transcription factor E4bp4, which plays
an essential role in NK cell ontogeny (Gascoyne et al., 2009) has
recently been shown to regulate IL-13 production (Motomura
et al., 2011). NK cells have also been reported to be activated
during murine infection with the ﬁlarial nematode Litomosoides
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sigmodontis, where they inﬂuence the balance of type-1 and type-2
cytokines (Korten et al., 2002), and to be an early source of IFN-γ
in Fasciola hepatica infection of rats (Tliba et al., 2002), but again
there is no information on the pathways of NK cell activation in
these infections.
FUNGAL ACTIVATION OF NK CELLS
Investigation of the role of NK cells in fungal infections is in its
very early stages but killing of diverse fungal species by NK cells
has been reported. NK cells are the main source of IFN-γ in the
early phase of Aspergillus fumigatus infection and are required to
induce killing of A. fumigatus by macrophages; depletion of either
NK cells or IFN-γ leads to an increase in fungal load (Park et al.,
2009). CCL2-dependent recruitment of NK cells is crucial in clear-
ing A. fumigatus infection in neutropenic mice (Morrison et al.,
2003).A. fumigatus hyphae are able to activate NK cells – although
the mechanism of activation has not been described – and NK
cells can kill A. fumigatus hyphae in a perforin-dependent manner
(Schmidt et al., 2011). However, it is also reported that A. fumi-
gatus hyphae modulate NK cell secretion of IFN-γ and GM-CSF
(Schmidt et al., 2011). NK cells are thought to mediate perforin-
dependent killing of Cryptococcus neoformans (Ma et al., 2004);
perforin release is mediated by PI3K-ERK1/2 signaling (Wiseman
et al., 2007). Finally, resistance to Candida albicans is correlated
with NK cell activation and NK cells are able to activate splenic
macrophages to phagocytose C. albicans (Algarra et al., 2002). To
date however, the mechanisms of activation of NK cells by fungi
have not been elucidated.
CONCLUDING REMARKS
There is now a strong body evidence to implicate NK cells
in effective control of a diverse array of pathogens, including
viruses, bacteria, protozoa, helminths, and fungi. Whilst many
of these infections can be contained in the absence of NK
cells, clearance of these organisms is almost always more efﬁ-
cient and more complete in the presence of a functional NK
cell response. NK cell activation by pathogens occurs predom-
inantly via the indirect pathway – involving cytokines and cell
contact-dependent signals from accessory cells. Whilst there
are many reports of direct NK cell activation by binding of
pathogen-derived molecules to NK cell surface receptors, in only
very few of these cases (MCMV and pox virus activation of
murine NK cells and activation of human NK cells by inﬂuenza
virus) have both the pathogen ligand and the NK cell recep-
tor been deﬁned at the gene and protein levels (Mandelboim
et al., 2001; Arase et al., 2002; Smith et al., 2002; Chisholm and
Reyburn, 2006). Validation of other putative pathogen-derived
ligands for NK cells awaits similar biochemical and genetic
information. Nevertheless, even where direct activation of NK
cells by pathogens has been conﬁrmed, the NK cell response
is further augmented by external cytokine and co-stimulatory
signals.
Two particularly interesting themes to have emerged from
recent studies of NK cell–pathogen interactions are the role of
T cell-derived IL-2 in amplifying NK cell responses – with obvi-
ous implications for augmentation of NK cell effector responses
by vaccination – and the potential for NK cells to take on reg-
ulatory or immunomodulatory roles, via secretion of IL-10 or
IL-13. These observations suggest that we have not yet real-
ized the full potential of NK cells to inﬂuence the outcome
of infectious diseases and suggest that further exploration of
the molecular basis of indirect NK cell activation – particu-
larly during helminth and fungal infections – could be extremely
rewarding.
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